Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$33,552,484
+$2,840,310 QoQ
Shares Held
132,112
+5.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#560
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. JNJ ranks #3 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,552,484 | 132,112 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $30,712,174 | 125,643 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $33,131,039 | 160,092 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $26,054,291 | 140,515 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $21,625,428 | 141,574 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $23,982,288 | 144,611 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $18,606,664 | 128,659 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $21,689,138 | 133,834 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $19,625,049 | 134,271 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $25,413,856 | 160,654 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $26,446,113 | 168,726 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $27,704,187 | 177,876 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $29,786,317 | 179,956 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $27,736,165 | 178,943 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $31,009,670 | 175,543 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $28,025,224 | 171,555 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $29,270,866 | 164,897 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $29,125,978 | 164,340 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $27,718,301 | 162,029 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $24,120,509 | 149,353 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $24,158,462 | 146,646 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $23,318,964 | 141,886 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $21,648,720 | 137,557 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $20,163,711 | 135,436 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $18,734,447 | 133,218 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $18,052,142 | 137,666 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||